Stock & Company Details
Aligos Therapeutics Inc $ALGS
Price:
N/A
N/A
6.2M
$33M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.61
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALGS technical indicators
Latest Aligos Therapeutics Inc (ALGS) indicator readings as of 2026-10-09.
ALGS's 14-day RSI is 42.5, in neutral territory. At $5.34 it is trading 18.7% below its 200-day moving average of $6.57, and below its 50-day average of $5.89. Price sits in the middle of its Bollinger Bands ($4.99 to $5.80). ADX reads 11.0, indicating a range-bound market rather than a trend.
Overview
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
Finance Bot
Ask your questions
Start by typing a question below.
